An Overview
-
The Converge Advisory Group serves as trusted and unbiased advisors by focusing exclusively on helping our clients bring innovative medicines to market faster and with a greater probability of success.
- We apply a broad and deep understanding of drug development and commercialization, based on 40+ years of combined experience, to help clients improve pipeline productivity throughout the lifecycle with strategic and operational support.
- We employ a unique and innovative consulting approach that leverages large and un-biased evidence-based strategies and flexible project delivery models.
- We design higher quality strategies faster than our competition by applying our combined 40+ years of experience, a machine-learning platform, and proven methodologies and tool sets.
Our Leadership
Subha B. Basu, PhD/MBA Managing Director
Subha co-founded and serves as a Managing Director with the Converge Advisory Group and has over 20 years of academic, industry and consulting experience.
Prior to co-founding the Converge Advisory Group, Subha held senior positions with Decision Resources Group, Quintiles Advisory Services, Frost & Sullivan and Becton Dickinson.
Subha has extensive exposure to opportunity assessment, emerging markets and strategy development in pharma, bioprocessing, medtech and biosimilars sectors.
Print